ArticleDiabetology & metabolic syndrome2015

Efficacy of dipeptidyl peptidase-4 inhibitor linagliptin in patients with type 2 diabetes undergoing hemodialysis.

Yuichi Terawaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.